MP73: Prostate Cancer: Localized: Ablative Therapy

Poster Session Moderator(s)

• 

  Hashim Ahmed, PhD (he/him/his)

  Chair and Professor of Urology
  Imperial College London
• 

  Aaron Katz, MD (he/him/his)

  Chairman
  NYU Langone-Long Island
• 

  Samuel Washington, III, MD

  Assistant Professor
  University of California, San Francisco

Presentations:

• 7:00 AM – 9:00 AM CST

  MP73-01: Does MRI or PSA Predict Biopsy Outcome after Focal Cryotherapy for Prostate Cancer?
  

  Poster Presenter: Wayne Brisbane, MD – UCLA Health
• 7:00 AM – 9:00 AM CST

  MP73-02: Focal therapy - 7 years experience with focal high intensity focused ultrasound in 164 patients with prostate cancer: single center results
  

  Poster Presenter: Yamini Nagaraj, MD,MBBS – Martini-Klinik, University Hospital Hamburg
• 7:00 AM – 9:00 AM CST

  MP73-03: The proportion of patients eligible for focal therapy of non-metastatic prostate cancer in the modern MRI-directed diagnostic pathway
  

  Poster Presenter: Deepika Reddy, MD (she/her/hers) – Imperial College London
• 7:00 AM – 9:00 AM CST

  MP73-04: External validation of a risk score predicting failure after salvage focal therapy for localized radiorecurrent prostate cancer: an analysis from the FOcal RECurrent Assessment and Salvage Treatment (FORECAST) trial
  

  Poster Presenter: Alexander Light, MBBS – Imperial College London
• 7:00 AM – 9:00 AM CST

  MP73-05: Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow up
  

  Poster Presenter: Christian Paul Pavlovich, MD – Johns Hopkins Hospital
• 7:00 AM – 9:00 AM CST

  MP73-06: Outcomes of Salvage Cryotherapy for biochemical recurrence following primary radiotherapy in the management of Prostate Cancer - 14-years Single Institution Experience
  

  Poster Presenter: Gregory Mansour, MD – EVMS - - Norfolk, VA
• 7:00 AM – 9:00 AM CST

  MP73-07: Oncological and Functional Outcomes of Men Undergoing Salvage Whole Gland Cryoablation of the Prostate
  

  Poster Presenter: Srinath Kotamarti, MD (he/him/his) – Duke University Medical Center
• 7:00 AM – 9:00 AM CST

  MP73-08: Focal ablative salvage therapy for radio-recurrent prostate cancer: a 10 year experience of oncological and safety outcomes in 276 patients
  

  Poster Presenter: Deepika Reddy, MD (she/her/hers) – Imperial College London
• 7:00 AM – 9:00 AM CST

  MP73-09: A retrospective clinical service evaluation of lesion-targeted MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of localized prostate cancer
  

  Poster Presenter: Rolf Muschter
• 7:00 AM – 9:00 AM CST

  MP73-10: Patient-Reported Treatment Related Regret (TRR) Following Primary Partial Gland Cryoablation (PPGCA):A Prospective Cohort Study of Men with Localized Prostate Cancer
  

  Poster Presenter: Eli Rapoport, MD,BS – New York University School of Medicine
• 7:00 AM – 9:00 AM CST

  MP73-12: Artificial Intelligence-based Cancer Mapping to Aid in Prostate Cancer Therapy
  

  Poster Presenter: Wayne Brisbane, MD – UCLA Health
• 7:00 AM – 9:00 AM CST

  MP73-13: MRI analysis of prostate morphometry and periprostatic anatomical relationships before and after partial high-intensity focused ultrasound treatment of localized prostate cancer.
  

  Poster Presenter: Denis Séguier, MD
• 7:00 AM – 9:00 AM CST

  MP73-14: Biopsy Assessment of Oncologic Control Three Years Following Primary Partial Gland Cryoablation (PPGCA)
  

  Poster Presenter: Eli Rapoport, MD,BS – New York University School of Medicine
• 7:00 AM – 9:00 AM CST

  MP73-15: Comparison of postoperative complications between Focal Ablation and Radical Prostatectomy for intermediate-risk prostate cancer: The FARP Randomized Control Trial.
  

  Poster Presenter: Eduard Baco
• 7:00 AM – 9:00 AM CST

  MP73-16: SUV variation on PSMA PET/CT correlates with biochemical response in patients with prostate cancer undergoing High-Intensity Focused Ultrasound (HIFU) focal therapy
  

  Poster Presenter: Vittorio Fasulo, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP73-17: Whole gland ablation using high-intensity focused ultrasound versus robot-assisted radical prostatectomy: a propensity score-matched study
  

  Poster Presenter: Jin Noh
• 7:00 AM – 9:00 AM CST

  MP73-18: Intermediate-term Oncologic and Functional Outcomes after Salvage Cryoablation for Localized, Biopsy-Proven Recurrent Prostate Cancer Following Primary External Beam Radiotherapy versus Primary Cryotherapy.
  

  Poster Presenter: Sriram Deivasigamani, MBBS, MS
• 7:00 AM – 9:00 AM CST

  MP73-19: Focal Cryoablation vs Focal High Intensity Focused Ultrasound for Intermediate and High-Risk Prostate Cancer
  

  Poster Presenter: Masatomo Kaneko, MD,PhD (he/him/his) – University of Southern California
• 7:00 AM – 9:00 AM CST

  MP73-20: IMPACT OFMULTIPARAMETRIC MRI EVALUATING 1 YEAR NEED FOR BIOPSY AFTER MR FUSION CRYOABLATION
  

  Poster Presenter: FARSHAD SHAFIZADEH